A multidisciplinary group that includes the University of Illinois at Urbana-Champaign and the University of Washington at Tacoma has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit in the format of a credit card.
The group is led by Illinois Electrical and Computer Engineering Professor Brian T. Cunningham; Illinois Bioengineering Professor Rashid Bashir; and, University of Washington at Tacoma Professor David L. Hirschberg, who is affiliated with Sciences and Mathematics, division of the School of Interdisciplinary Arts and Sciences.
Findings have been published in Analytical Chemistry, demonstrating detection of four horse respiratory diseases, and in Biomedical Microdevices, where the system was used to detect and quantify the presence of Zika, Dengue, and Chikungunya virus in a droplet of whole blood. Project collaborators include Dr. David Nash, a private practice equine expert and veterinarian in Kentucky, and Dr. Ian Brooks, a computer scientist at the National Center for Supercomputing Applications.
The low-cost, portable, smartphone-integrated system provides a promising solution to address the challenges of infectious disease diagnostics, especially in resource-limited settings or in situations where a result is needed immediately. The diagnostic tool’s integration with mobile communications technology allows personalized patient care and facilitates information management for both healthcare providers and epidemiological surveillance efforts. Importantly, the system achieves detection limits comparable to those obtained by laboratory-based methods and instruments, in about 30 minutes.
A useful capability for human point-of-care (POC) diagnosis or for a mobile veterinary laboratory, is to simultaneously test for the presence of more than one pathogen with a single test protocol, which lowers cost, saves time and effort, and allows for a panel of pathogens, which may cause similar symptoms, to be identified.
Infectious diseases remain the world’s top contributors to human death and disability, and with recent outbreaks of Zika virus infections, there is a keen need for simple, sensitive, and easily translatable point-of-care tests. Zika virus appeared in the international spotlight in late 2015 as evidence emerged of a possible link between an epidemic affecting Brazil and increased rates of microcephaly in newborns. Zika has become a widespread global problem—the World Health Organization (WHO) documented last year that since June 2016, 60 nations and territories report ongoing mosquito-borne transmission. Additionally, since Zika virus infection shares symptoms with other diseases such as Dengue and Chikungunya, quick, accurate diagnosis is required to differentiate these infections and to determine the need for aggressive treatment or quarantine.
For the research effort, horses were used as an animal model for respiratory disease in man and food animals. Says Dr. David Nash “You can often more easily develop diagnostic tools for human use by coming in to development from the animal side of things first. Many diseases show up first in animals, kind of the canary in the coal mine.”
A key project contributor, Dr. Nash comments on the financial impact of infectious disease outbreaks in horses: “It’s costly to horse owners and trainers, and disrupts the business operations of all equine sports. Consider this—on December 25, 2016 a single horse stabled at the Fair Grounds Race Course in New Orleans experienced a fever and subsequently developed neurological symptoms. The state diagnostic lab was 100 miles away and was closed for the Christmas holiday. The end result was an equine herpesvirus-1 (EHV-1) outbreak that resulted in the quarantine of over 200 horses at the racetrack and a serious financial loss for horse owners and the racetrack owner, Churchill Downs, Inc. Imagine the consequences if they ever had to postpone the Kentucky Derby due to a disease outbreak.”
The technology is intended to enable clinicians to rapidly diagnose disease in their office or in the field, resulting in earlier, more informed patient management decisions, while markedly improving the control of disease outbreaks. An important prerequisite for the widespread adoption of point-of-care tests at the patient’s side is the availability of detection instruments that are inexpensive, portable, and able to share data wirelessly over the Internet.
The system uses a commercial smartphone to acquire and interpret real-time images of an enzymatic amplification reaction that takes place in a silicon microfluidic chip that generates green fluorescence and displays a visual read-out of the test. The system is composed of an unmodified smartphone and a portable 3D–printed cradle that supports the optical and electrical components, and interfaces with the rear-facing camera of the smartphone.
The software application operating on the smartphone gathers information about the tests conducted on the microfluidic card, patient-specific information, and the results from the assays, that are then communicated to a cloud storage database.
Dr. Nash observes that, “This project is a game changer. This is the future of medicine—empowered front-line healthcare professionals. We can’t stop viruses and bacteria, but we can diagnose more quickly. We were able to demonstrate the clear benefit to humankind, as well as to animals, during the proposal phase of the project, and our results have proved our premise. Next, I want to go into the field, multiple sites, multiple geographic locations, and test in real-world situations.”
U of I graduate student and research assistant Fu Sun sees this project as fulfillment of one of her primary career objectives: “I entered graduate school with the hope to make a better world by developing biomedical devices that can facilitate effective disease prevention, diagnosis, or treatment. This project is in line with my goal since it provides a point-of-care solution for the fast diagnosis of infectious diseases. Connected to a cloud database through a smartphone, it helps healthcare providers in the field embrace the era of big data and the Internet of Things.”
The system represents the only platform to date that can multiplex detection of viral and other nucleic acid targets on a portable point-of-care setup using one droplet of bodily fluid, including whole blood.
The Latest on: Detecting pathogens
- New research reveals how dogs can detect epileptic seizures up to 45 minutes before they happen on April 18, 2019 at 7:30 am
That means they can detect a few scent molecules among trillions of them. Scientists are now trying to build electronic noses that are just as powerful. The idea is that they too could be used to ... […]
- PathAI raises $60 million for its computer vision-based pathogen detection technology on April 17, 2019 at 6:36 pm
With a clinical version of PathAI‘s computer vision-based pathogen detection service still at least one year from coming to market, the diagnostic technology developer has snagged $60 million in ... […]
- Direct detection of bacteremia by exploiting host-pathogen interactions of lipoteichoic acid and lipopolysaccharide on April 17, 2019 at 8:07 am
Bacteremia is a leading cause of death in sub-Saharan Africa where childhood mortality rates are the highest in the world. The early diagnosis of bacteremia and initiation of treatment saves lives, ... […]
- Protein Detection And Quantification Market: Opportunities in Upcoming Years Based on Market Share, Size, Supply Volume and Key Regions on April 17, 2019 at 6:10 am
In addition, increasing need to study chronic diseases at the molecular level in order to develop novel therapeutics is another factor expected to drive growth of global protein detection and ... […]
- China provides Fiji medical equipments to detect non-communicable diseases on April 17, 2019 at 12:06 am
SUVA, April 17 (Xinhua) -- The Fijian government received medical equipments from China on Wednesday, in collaboration with the World Health Organization, to help health experts to detect and cure ... […]
- Disease detection in a box – a high-tech solution for emergency settings on April 16, 2019 at 4:38 am
Under the leadership of the Ministry of Health, WHO is rolling out its early warning alert and response system (known as EWARS-in-a-Box) to rapidly detect priority epidemic-prone diseases and allow a ... […]
- Medical Radiation Detection, Monitoring & Safety Market Technologies and Global Insights to 2023 on April 16, 2019 at 1:08 am
Radiation Detection, Monitoring & Safety products provides safety ... owing to the presence of well-established players and increasing prevalence of cancer diseases. Europe is expected to hold the ... […]
- CERTUS™ Releases Empower™ Pathogen Environmental Monitoring Software Providing Strengthened and Streamlined In-House Control on April 16, 2019 at 1:04 am
Digital platform provides intuitive, cost-effective solution for producers combining scheduling and workflow tracking with early pathogen detection leading to a quicker remediation response ... […]
- Zeteo Tech Awarded $6.5M DHS S&T Contract to Develop and Test digitalMALDI™ Real-Time Biological Threat Detection Technology on April 15, 2019 at 5:36 am
to develop and test a new sensor technology that enables real-time detection of aerosolized biological threat agents including bacteria, viruses, and toxins. The contract was awarded in support of ... […]
- Spotlight on ECCMID 2019: Detecting Disease & Managing Infections on April 15, 2019 at 4:53 am
This technology is the “first and only” chemiluminescence-based (CLIA) detection solution in European markets. The ability to trace disease outbreaks and genotype pathogens is key to preventing the ... […]
via Google News and Bing News